Tomonori Oka

5PUBLICATIONS
29CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 13, 2026
Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma.

Kenta Oka, Takuya Miyagawa, Hiromichi Morita

|Jan 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.

Jun Tian, Jonathan H Chen, Sherry X Chao

|Aug 07, 2021
CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.

Minami Sakamoto, Tomomitsu Miyagaki, Hiroaki Kamijo

|Mar 06, 2021
Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis.

Sohshi Morimura, Makoto Sugaya, Tomonori Oka

|Apr 09, 2017
CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.

Tomonori Oka, Makoto Sugaya, Naomi Takahashi

Pageof 1

Frequent Collaborators

3 joint publications

Makoto Sugaya

3 joint publications

Tomomitsu Miyagaki

2 joint publications

Yoshihide Asano

1 joint publications

Shinichi Sato